Boston Trust Walden Corp cut its holdings in Plexus Corp. (NASDAQ:PLXS – Free Report) by 12.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 296,479 shares of the technology company’s stock after selling 42,671 shares during the quarter. Boston Trust Walden Corp’s holdings in Plexus were worth $60,049,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Covestor Ltd raised its stake in shares of Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock worth $35,000 after acquiring an additional 162 shares during the last quarter. Allworth Financial LP grew its stake in shares of Plexus by 70.1% during the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after purchasing an additional 103 shares during the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Plexus in the third quarter valued at approximately $72,000. Farther Finance Advisors LLC increased its holdings in shares of Plexus by 114.7% in the fourth quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock valued at $75,000 after purchasing an additional 273 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in Plexus by 583.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after purchasing an additional 490 shares during the last quarter. 94.45% of the stock is owned by institutional investors.
Plexus Trading Down 5.2%
NASDAQ PLXS opened at $275.11 on Friday. Plexus Corp. has a 12 month low of $115.35 and a 12 month high of $307.06. The stock has a 50-day simple moving average of $273.37 and a 200 day simple moving average of $218.94. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $7.36 billion, a PE ratio of 40.22 and a beta of 0.88.
Analysts Set New Price Targets
Several research firms have issued reports on PLXS. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Needham & Company LLC raised their price target on Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a report on Monday, June 1st. Benchmark reiterated a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research report on Monday, March 16th. Zacks Research lowered shares of Plexus from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 20th. Finally, Stifel Nicolaus lifted their price target on shares of Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $246.67.
View Our Latest Report on Plexus
Insider Activity
In related news, insider Victor (Pang Hau) Tan sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $271.23, for a total transaction of $813,690.00. Following the completion of the transaction, the insider owned 10,457 shares in the company, valued at approximately $2,836,252.11. The trade was a 22.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $264.75, for a total transaction of $865,732.50. Following the completion of the sale, the executive vice president directly owned 16,266 shares of the company’s stock, valued at $4,306,423.50. The trade was a 16.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 21,981 shares of company stock valued at $5,855,318. Insiders own 1.78% of the company’s stock.
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Plexus
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
